Related Experiment Videos
Temocillin pharmacokinetics in normal and impaired renal function
Drugs
|January 1, 1985
Summary
Temocillin dosing requires adjustment in patients with impaired renal function due to non-linear pharmacokinetics. Higher doses did not proportionally increase plasma concentrations, necessitating dose-reduction factors for optimal therapeutic levels.
Area of Science:
- Pharmacokinetics and Drug Metabolism
- Nephrology and Renal Function Studies
- Antibiotic Therapy and Clinical Pharmacology
Background:
- Temocillin is an antibiotic requiring careful dosing, especially in patients with compromised kidney function.
- Understanding temocillin's pharmacokinetic profile is crucial for safe and effective therapeutic use.
- Previous studies may not have fully elucidated the dose-dependent behavior of temocillin in renal impairment.
Purpose of the Study:
- To determine plasma concentrations of temocillin after intravenous and intramuscular administration in healthy volunteers and patients with renal impairment.
- To investigate the pharmacokinetic behavior of temocillin, particularly its dose proportionality and clearance mechanisms.
- To establish dose-reduction factors for optimizing temocillin dosing regimens in patients with varying degrees of renal dysfunction.
Main Methods:
- Intravenous administration of temocillin (0.5, 1, and 2g) to 18 healthy volunteers and 18 patients with renal impairment.
- Intramuscular administration of temocillin (0.5g) to a separate group of 6 patients.
- Measurement of plasma concentrations and calculation of area under the plasma concentration-time curve (AUC) to assess pharmacokinetics.
Main Results:
- Temocillin exhibited non-linear pharmacokinetics; higher doses did not proportionally increase plasma concentrations or AUC.
- Both renal and total clearance of temocillin increased with higher doses, indicating saturation or altered elimination pathways.
- Patients with renal impairment showed significantly higher plasma concentrations compared to healthy subjects, necessitating dose adjustments.
Conclusions:
- Temocillin's pharmacokinetic profile is dose-dependent and non-linear, particularly impacting its clearance.
- Specific dose-reduction factors are required to achieve target plasma concentrations in patients with impaired renal function.
- The unique behavior of temocillin limits the universal applicability of these factors across all doses, emphasizing the need for individualized dosing strategies.